Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Global cancer statistics.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.

CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):134.

2.

Do changes in cigarette design influence the rise in adenocarcinoma of the lung?

Burns DM, Anderson CM, Gray N.

Cancer Causes Control. 2011 Jan;22(1):13-22. doi: 10.1007/s10552-010-9660-0. Epub 2010 Oct 22.

3.

Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors.

Brenner DR, Hung RJ, Tsao MS, Shepherd FA, Johnston MR, Narod S, Rubenstein W, McLaughlin JR.

BMC Cancer. 2010 Jun 14;10:285. doi: 10.1186/1471-2407-10-285.

4.

History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada.

El-Zein M, Parent ME, Kâ K, Siemiatycki J, St-Pierre Y, Rousseau MC.

Ann Allergy Asthma Immunol. 2010 May;104(5):378-84. doi: 10.1016/j.anai.2010.03.003.

PMID:
20486327
5.

Lung cancer in a U.S. population with low to moderate arsenic exposure.

Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ.

Environ Health Perspect. 2009 Nov;117(11):1718-23. doi: 10.1289/ehp.0900566. Epub 2009 Jul 2.

6.

Risk of lung cancer following nonmalignant respiratory conditions among nonsmoking women living in Shenyang, Northeast China.

Liang H, Guan P, Yin Z, Li X, He Q, Zhou B.

J Womens Health (Larchmt). 2009 Dec;18(12):1989-95. doi: 10.1089/jwh.2008.1355.

PMID:
20044861
7.

Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.

Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, Chaturvedi AK, Wacholder S, Landi MT, Lubin JH, Caporaso NE.

PLoS One. 2009 Oct 8;4(10):e7380. doi: 10.1371/journal.pone.0007380.

8.

Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, Rudin CM.

Clin Cancer Res. 2009 Sep 15;15(18):5626-45. doi: 10.1158/1078-0432.CCR-09-0376. Review.

9.

Asthma and . . . what is the link?

Kabesch M.

Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):393-4. No abstract available.

PMID:
19697447
10.

Deaths with asthma in France, 2000-2005: a multiple-cause analysis.

Fuhrman C, Jougla E, Uhry Z, Delmas MC.

J Asthma. 2009 May;46(4):402-6. doi: 10.1080/02770900902795553.

PMID:
19484678
11.

Asthma.

Fanta CH.

N Engl J Med. 2009 Mar 5;360(10):1002-14. doi: 10.1056/NEJMra0804579. Review. No abstract available. Erratum in: N Engl J Med. 2009 Sep 10;361(11):1123. N Engl J Med. 2009 Apr 16;360(16):1685.

PMID:
19264689
12.

Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.

Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC, Gadgeel S, Soubani AO.

J Thorac Oncol. 2009 Mar;4(3):291-9. doi: 10.1097/JTO.0b013e3181951cd1.

13.

Cancer risk in hospitalised asthma patients.

Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K.

Br J Cancer. 2009 Mar 10;100(5):829-33. doi: 10.1038/sj.bjc.6604890. Epub 2009 Jan 27.

14.

Allergies: their role in cancer prevention.

Sherman PW, Holland E, Sherman JS.

Q Rev Biol. 2008 Dec;83(4):339-62. Review.

PMID:
19143335
15.

The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.

Ugolini D, Neri M, Canessa PA, Casilli C, Catrambone G, Ivaldi GP, Lando C, Marroni P, Paganuzzi M, Parodi B, Visconti P, Puntoni R, Bonassi S.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3013-9. doi: 10.1158/1055-9965.EPI-08-0524. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1331. multiple author names corrected.

16.

DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors.

Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, Clas BA, Downey R, Flores R, Bains M, Rizk N, Dominguez G, Jani J, Berwick M, Begg CB, Kris MG, Rusch VW.

J Clin Oncol. 2008 Jul 20;26(21):3560-6. doi: 10.1200/JCO.2007.13.2654.

17.

The challenge of differentiating asthma from chronic obstructive pulmonary disease.

Hanania NA.

Manag Care. 2005 Jul;14(7 Suppl Obstructie Lung):9-15; discussion 24-6. No abstract available.

18.

Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.

Sauter W, Rosenberger A, Beckmann L, Kropp S, Mittelstrass K, Timofeeva M, Wölke G, Steinwachs A, Scheiner D, Meese E, Sybrecht G, Kronenberg F, Dienemann H; LUCY-Consortium, Chang-Claude J, Illig T, Wichmann HE, Bickeböller H, Risch A.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1127-35. doi: 10.1158/1055-9965.EPI-07-2840.

19.

Inflammation in the development of lung cancer: epidemiological evidence.

Engels EA.

Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15. doi: 10.1586/14737140.8.4.605. Review.

PMID:
18402527
20.

Comparison of aspects of smoking among the four histological types of lung cancer.

Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA.

Tob Control. 2008 Jun;17(3):198-204. doi: 10.1136/tc.2007.022582. Epub 2008 Apr 4.

Supplemental Content

Support Center